No Data
No Data
Form 144 | Celldex Therapeutics(CLDX.US) Officer Proposes to Sell 703.33K in Common Stocks
SEC FILLINGS DISCLOSED/ May 30, $Celldex Therapeutics(CLDX.US)$ Officer Cavanaugh Sarah intends to sell 20,853 shares of its common stock on May 30, with a total market value of approximately $703.33K
Form 144 | Celldex Therapeutics(CLDX.US) Officer Proposes to Sell 1.19 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 30, $Celldex Therapeutics(CLDX.US)$ Officer Martin Samuel Bates intends to sell 35,000 shares of its common stock on May 30, with a total market value of approximately $1.1
Form 144 | Celldex Therapeutics(CLDX.US) Officer Proposes to Sell 144K in Common Stocks
SEC FILLINGS DISCLOSED/ May 30, $Celldex Therapeutics(CLDX.US)$ Officer Crowley Elizabeth intends to sell 38,597 shares of its common stock on May 30, with a total market value of approximately $144K.
Form 144 | Celldex Therapeutics(CLDX.US) Director Proposes to Sell 3.53 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 30, $Celldex Therapeutics(CLDX.US)$ Director Heath-Chiozzi Margo intends to sell 97,088 shares of its common stock on May 30, with a total market value of approximately $3.
Wall Street Analysts Think Celldex (CLDX) Could Surge 87.27%: Read This Before Placing a Bet
Shares of Celldex Therapeutics (CLDX) have gained 1.7% over the past four weeks to close the last trading session at $36.92, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication.
Express News | Celldex Doses First Patient In Phase 2 Study Of Barzolvolimab In Prurigo Nodularis
No Data